Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.34 USD | -0.93% |
|
+6.80% | +6.59% |
Jul. 11 | Abeona Therapeutics Partners with Beacon Therapeutics to Develop Ophthalmic Gene Therapies | MT |
Jul. 11 | Abeona Therapeutics Inc. and Beacon Therapeutics Announce Non-Exclusive Agreement | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.59% | 219M | |
+25.83% | 47.96B | |
+45.38% | 41.47B | |
+0.69% | 42.45B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- Abeona Therapeutics Inc. Announces Appointment of Michael Amoroso as President and a Member of the Company's Board of Directors